PMS69 Tumor Necrosis Factor Blocker Dose Escalation among Biologic Naïve Rheumatoid Arthritis (RA) Patients in Commercial Managed Care Plans in the Two Years Following Therapy Initiation
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.258
https://www.valueinhealthjournal.com/article/S1098-3015(12)00323-3/fulltext
Title :
PMS69 Tumor Necrosis Factor Blocker Dose Escalation among Biologic Naïve Rheumatoid Arthritis (RA) Patients in Commercial Managed Care Plans in the Two Years Following Therapy Initiation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00323-3&doi=10.1016/j.jval.2012.03.258
First page :
A46
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
1031